Best Value Stocks to Buy for October 16th

A Zacks roundup highlights three stocks with Rank #1 and value characteristics: Ultrapar, whose current-year earnings consensus rose 7.7% over 60 days; ScanSource, up 11.9%; and Piedmont Realty Trust, whose next-year estimate increased 0.7%. The article also argues that AI’s next growth wave will shift from infrastructure to implementation, but provides no specific forecasts or market reactions.

Analysis

This is a screening signal, not evidence that any of the three companies is an AI beneficiary. The AI framing risks creating a thematic halo around businesses whose near-term earnings drivers may be unrelated. SCSC is the only plausible second-order AI read-through: as a technology distributor, it could benefit if enterprise AI deployment lifts demand for networking, security, and compute equipment, but distribution economics may not capture much of the end-user value. Verify product mix, gross-profit dollars, inventory, and vendor terms before treating estimate revisions as durable. UGP and PDM should be underwritten on their own operating drivers, not the AI narrative: energy/infrastructure exposure for UGP and property cash flows, leasing, and financing conditions for PDM. The stated estimate changes provide no information on revision breadth, starting valuation, or what changed in assumptions.

Immediate reaction: likely limited absent fresh company-specific news; the promotional AI association could nevertheless attract short-lived attention to SCSC. Over 1–3 months, check earnings guidance and whether estimate revisions translate into reported results. Over 6–18 months, AI implementation could support distributor demand, but substitution, vendor concentration, and weak pass-through could limit returns; for PDM, rates and leasing fundamentals are more consequential, while UGP remains exposed to its own market and policy drivers. Contrarian point: a positive revision screen is not automatically undervaluation, and calling these names the “second wave” may overstate the evidence. No directional trade is justified from this article alone.

Key Decisions for Investors

• Do not buy SCSC as an AI proxy on this article. Put it on a watchlist and verify the source of revisions, AI-related revenue or order contribution, gross-profit conversion, inventory, and subsequent guidance.
• Keep UGP and PDM outside the AI basket; assess UGP against relevant energy/infrastructure and currency drivers, and PDM against occupancy, leasing spreads, debt maturities, and interest-rate sensitivity.
• If considering SCSC, wait for company-specific evidence that demand is broadening and gross-profit dollars are improving—not merely higher consensus EPS. Falsify the constructive case if guidance or reported gross profit fails to confirm revisions, or inventory rises faster than sales.
• Before any valuation-based position, obtain current valuation, estimate-revision breadth and assumptions, and balance-sheet data; the article supplies none of these, so there is no defensible entry level or risk/reward estimate.